•
Oct 30, 2020

Medtronic Q2 2021 Earnings Report

Medtronic's Q2 2021 financial results were reported.

Key Takeaways

Medtronic reported a decrease in revenue by 0.8% to $7.6 billion. The GAAP diluted EPS was $0.36, and the non-GAAP diluted EPS was $1.02.

Q2 Revenue of $7.6 Billion decreased 0.8% as reported and 1.5% organic.

Q2 GAAP Diluted EPS of $0.36

Q2 Non-GAAP Diluted EPS of $1.02

Second quarter U.S. revenue of $4.054 billion represented 53 percent of company revenue and decreased 2 percent as reported and organic.

Total Revenue
$7.65B
Previous year: $7.71B
-0.8%
EPS
$1.02
Previous year: $1.31
-22.1%
Total Organic Revenue Growth
-1.5%
Gross Profit
$4.94B
Previous year: $5.31B
-7.0%
Cash and Equivalents
$6.42B
Previous year: $3.96B
+62.0%
Free Cash Flow
$1.58B
Previous year: $1.58B
-0.3%
Total Assets
$95.9B
Previous year: $91.1B
+5.3%

Medtronic

Medtronic

Medtronic Revenue by Segment

Medtronic Revenue by Geographic Location

Forward Guidance

Given the uncertainty on near-term financial results caused by the COVID-19 pandemic, the company is not providing formal annual or quarterly financial guidance at this time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income